Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
A new selectable marker gene The GUSPlusTM project A new GUS gene, Available under BIOSTM licensing, Pioneering use of the BioForgeTM concept TM Why do we want extra-cellular GUS? • Superiority and familiarity of GUS as a reporter protein • Assays with E.coli GUS are almost always destructive • Secreted protein should allow in vivo assays • New biological possibilities with externally applied glucuronide-conjugated biomolecules TM GUSPlusTM is a more sensitive reporter than E.coli GUS Rice anthers and style showing GUSPlusTM expression TM Properties of GUSPlusTM √ Almost identical in size to E.coli GUS (602 vs 603aa) √ 47% amino acid identity with E.coli GUS √ Secreted in Staphylococcus spp. and E.coli, no signal peptide needed √ One cysteine vs nine in E. coli GUS √ Excellent stability and catalytic properties X AT-rich coding gene, giving lower expression in heterologous systems Synthetic GUSPlusTM gene construction • codon usage optimised for plants • eliminated unwanted signals: polyA, splice sites, unwanted restriction sites • minimised potential secondary structures • introduced useful restriction sites • GusPlus gene rebuilt from oligos TM GUSPlusTM has lower Km, similar Vmax to E.coli GUS 1/v (nmol-1·mg·min) 0.04 0.03 0.02 BGUS -1/Km -20 1/Vmax 0.01 -10 BGUS EGUS 0 10 Km Vmax EGUS 40 mM 120 mM 80 80 -1 nmol.mg min-1 20 1/[pNPG] (mM -1) TM GUSPlusTM has enhanced activity, and improved thermal stability 60°C Relative activity (%) 100 80 60 40 GUSPlus E.coli GUS 20 0 0 20 40 60 80 Temperature (°C) 0 10 20 30 Time (min) TM GUSPlusTM and E.coli GUS have similar, broad pH optima Activity (nmol·mg -1·min-1) 100 80 60 40 20 GUSPlus E. coli GUS 0 5 6 7 8 9 pH TM GUSPlusTM has improved chemical resistances Relative activity (%) 120 100 GUSPlus E. coli GUS Assayed with 0.25mM pNPGlcA 80 60 40 20 0 TM GUSPlusTM with signal peptide is secreted B GUSPlus ExtSP-GUSPlus (+ Extensin signal peptide) GRP-SP-GUSPlus (+ GRP signal peptide) Sections of rice root stained yellow-green by activity of GUSPlusTM using ELF-97-GlcA substrate. • GRP signal peptide directs GUSPlusTM to cell wall apoplastic space more efficiently than extensin signal peptide TM New possibilities with a secreted GUS • Non-destructive, high sensitivity in vivo staining for qualitative gene expression analysis • Treatment of GUSPlus-secreting cells with apoplastically-transportable/diffusible glucuronideconjugated effector molecules • Use as screenable marker gene • Use as selectable marker gene TM How will this technology be available for use by the agricultural R&D community? • Traditional intellectual property licenses contain covenants under which the licensee must agree to: • Royalties and/or milestone payments • Exclusive or non-exclusive licence, with various restrictions on field of use • (often) Grantback of improvements to licensor • (often) Assistance to licensor in maintaining patent monopoly TM GusPlus is available for use under the conditions of a BIOS license TM TM Traditional intellectual property licenses contain covenants under which the licensee must agree to: • • • • Royalties and/or milestone payments Exclusive or non-exclusive, with various restrictions on field of use (often) Grantback of improvements to licensor (often) Assistance to licensor in maintaining patent monopoly BIOS -compliant IP licenses will instead contain covenants under which the licensee must agree to: TM • No royalties, only costs of maintaining protected commons • Non-exclusive only • Sharing of improvements and technology data for regulatory purposes • No assertion of improvement patent rights against other licensees TM BIOS licenses will be granted to entities that agree to the covenants: • Universities • Public good research institutions • Private companies, small, medium or large, wanting to use and improve the technology to make products The intent of the improvement-sharing and non-assertion requirements is that no one licensee can hijack the technology, and it can be used - for humanitarian purposes or - to make a profit TM The GusPlus™ project Funded by the Rockefeller Foundation and Horticulture Australia A new ß-glucuronidase gene Tuan Nyugen, Peter Wenzl, Brian Weir, Heidi Mitchell, Leon Smith, Richard Jefferson BIOSTM licensing Draft License: Mat Berman (UC) Mike Rabson, Marie Connett Porceddu, Richard Jefferson; Commentable website: Steve Irwin, Nick dos Remedios; to be jointly hosted with Science Commons BioForgeTM distributive collaboration website Collabnet® and CAMBIA’s BIOS Initiative